The rise of fentanyl abuse poses significant challenges to workplace safety and productivity. Addressing these challenges requires comprehensive understanding and proactive measures. In a recent webinar, Lance Presley, an expert from Labcorp, discussed the impact of fentanyl on the workplace and the critical steps employers should take to mitigate its risks. Here's what you need to know.
A Brief History of Fentanyl
Fentanyl, a potent synthetic opioid, was first synthesized in 1959 and approved for medical use in 1968, primarily for its anesthetic and analgesic properties. Its potency makes it a dangerous substance when misused. Over the years, various analogs of fentanyl have been developed, some for medical use and others for veterinary purposes. For instance, Carfentanil, a tranquilizer for large animals, is 10,000 times more potent than morphine.
The Rising Threat of Fentanyl
The abuse of fentanyl has escalated dramatically in recent years, leading to a surge in overdose deaths. According to data from the DEA, while the amount of cocaine seized has decreased since 2021, the amount of fentanyl seized has steadily increased. Since 2021, the amount of deaths due to fentanyl have also steadily increased, with currently over 50,000 traceable deaths in 2023 alone when compared to cocaine, methamphetamine, heroin, and other opiates. This trend underscores the urgent need for awareness and preventive measures, especially in the workplace.
Fentanyl Lab Studies and Impacts on Workplace Safety
Fentanyl's impact extends beyond public health, significantly affecting workplace safety and productivity. Employers must understand the risks associated with fentanyl use among employees and implement comprehensive drug testing and prevention programs. One of the critical steps in managing fentanyl abuse is effective testing. Studies from workplace labs have shown an alarming increase in the prevalence of fentanyl in drug tests. Labcorps study highlights the shifting landscape of polydrug use combining heroin with designer opioids. Further testing looked for the presence of fentanyl, fentanyl analogs, and other designer opioids or related compounds. By far, fentanyl is the dominant synthetic opioid consumed by heroin users in the US. No other designer opioids appeared more prevalent or consistently between 2016 and 2024. Another lab indicated that nearly 3% of all specimens tested for fentanyl were positive in 2023, a rate approaching that of marijuana.
Federal Regulations and Workplace Policies
The federal government has recognized the need to include fentanyl in drug testing panels. In 2023, HHS proposed guidelines to add fentanyl to the federal workplace drug testing panel. Earlier in March 2024, guidelines were discussed and slightly revised with the Federal Urine Drug Testing Panel recommending screening each federal sample at 1ng/mL for the initial test and then perform confirmation testing for fentanyl and Norfentanyl at 1ng/mL too. Once these guidelines are finalized, they will likely influence DOT regulations and workplace drug testing policies across various industries.
What Can DISA Do?
Fentanyl poses a severe threat to workplace safety and productivity. By understanding its impact and implementing robust preventive measures, employers can help mitigate the risks associated with this powerful opioid. DISA can help employers stay informed, vigilant, and prioritize the well-being of their workforce, taking proactive steps to address fentanyl abuse. This includes implementing comprehensive drug policies that ensure fentanyl is included in workplace drug testing panels and policies. Additionally, educating employees on the dangers of fentanyl and the importance of workplace safety is crucial. Offering support and resources, such as access to counseling and rehabilitation services for employees struggling with substance abuse, can make a significant difference.
Related Articles
Drug Testing 2024: THC, Fentanyl, Challenges
Fentanyl Awareness Day: Impact On Communities and Workplaces
About DISA Global Solutions
Founded in 1986, DISA is the industry-leading provider of employee screening and compliance services. Headquartered in Houston, with more than 35 offices throughout North America and Europe, DISA’s comprehensive scope of services includes drug and alcohol testing, background screening, occupational health, and transportation compliance. DISA assists employers in making informed staffing decisions while building a culture of safety in their workplace.